Sanofi (SNYNF) Accounts Payables (2009 - 2025)

Sanofi (SNYNF) has 17 years of Accounts Payables data on file, last reported at $8.6 billion in Q4 2025.

• Quarterly Accounts Payables rose 6.19% year-over-year to $8.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 billion (up 6.19% YoY) and the FY2025 annual result came in at $8.6 billion, up 6.19% from the prior year.
• Accounts Payables climbed to $8.6 billion in Q4 2025 per SNYNF's latest filing, from $8.0 billion in the prior quarter.
• The five-year high for Accounts Payables was $8.6 billion in Q4 2025, with the low at $6.5 billion in Q2 2021.
• Average Accounts Payables over 5 years is $7.6 billion, with a median of $7.9 billion recorded in 2023.
• Year-over-year, Accounts Payables increased 19.42% in 2021 and retreated 1.68% in 2022.
• Sanofi's Accounts Payables stood at $7.1 billion in 2021, then fell by 1.68% to $7.0 billion in 2022, then grew by 13.43% to $7.9 billion in 2023, then climbed by 2.34% to $8.1 billion in 2024, then rose by 6.19% to $8.6 billion in 2025.
• Business Quant data shows SNYNF's Accounts Payables at $8.6 billion in Q4 2025, $8.0 billion in Q2 2025, and $8.1 billion in Q4 2024.